• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Rev Med Virol . Targeting the mammalian target of rapamycin pathway in neurological manifestations of Covid-19

tetano

Editor, Senior Moderator
Rev Med Virol


. 2024 Jan;34(1):e2503.
doi: 10.1002/rmv.2503. Targeting the mammalian target of rapamycin pathway in neurological manifestations of Covid-19

Han Wang[SUP] 1 [/SUP], Li Cheng[SUP] 1 [/SUP], Lanlan Yu[SUP] 1 [/SUP], Zhigang Guo[SUP] 2 [/SUP]



Affiliations
Abstract

The diverse and severe nature of neurological manifestations associated with coronavirus disease 2019 (Covid-19) has garnered increasing attention. Exploring the potential to decrease neurological complications in Covid-19 patients involves targeting the mammalian target of rapamycin (mTOR) pathway as a therapeutic strategy. The mTOR pathway, widely recognised for its central role in essential cellular processes like synthesising proteins, facilitating autophagy, and modulating immune responses, has implications in various neurological disorders. Drawing parallels between these disorders and the observed neurological complications in Covid-19, we present a comprehensive review on the current understanding of mTOR signalling in the context of severe acute respiratory syndrome coronavirus 2 infection and neuroinflammation.

Keywords: Covid-19; mTOR pathway; neurological manifestations; therapeutic targeting.

 
Back
Top Bottom